293 related articles for article (PubMed ID: 32763265)
1. Nonadherence or Nonpersistence to Intravitreal Injection Therapy for Neovascular Age-Related Macular Degeneration: A Mixed-Methods Systematic Review.
Okada M; Mitchell P; Finger RP; Eldem B; Talks SJ; Hirst C; Paladini L; Barratt J; Wong TY; Loewenstein A
Ophthalmology; 2021 Feb; 128(2):234-247. PubMed ID: 32763265
[TBL] [Abstract][Full Text] [Related]
2. Defining Nonadherence and Nonpersistence to Anti-Vascular Endothelial Growth Factor Therapies in Neovascular Age-Related Macular Degeneration.
Okada M; Wong TY; Mitchell P; Eldem B; Talks SJ; Aslam T; Daien V; Rodriguez FJ; Gale R; Barratt J; Finger RP; Loewenstein A
JAMA Ophthalmol; 2021 Jul; 139(7):769-776. PubMed ID: 34081099
[TBL] [Abstract][Full Text] [Related]
3. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.
Solomon SD; Lindsley K; Vedula SS; Krzystolik MG; Hawkins BS
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD005139. PubMed ID: 30834517
[TBL] [Abstract][Full Text] [Related]
4. Anti-Vascular Endothelial Growth Factor Use and Atrophy in Neovascular Age-Related Macular Degeneration: Systematic Literature Review and Expert Opinion.
Sadda SR; Guymer R; Monés JM; Tufail A; Jaffe GJ
Ophthalmology; 2020 May; 127(5):648-659. PubMed ID: 32081493
[TBL] [Abstract][Full Text] [Related]
5. Loss to Follow-up Among Patients With Neovascular Age-Related Macular Degeneration Who Received Intravitreal Anti-Vascular Endothelial Growth Factor Injections.
Obeid A; Gao X; Ali FS; Aderman CM; Shahlaee A; Adam MK; Kasi SK; Hyman L; Ho AC; Hsu J
JAMA Ophthalmol; 2018 Nov; 136(11):1251-1259. PubMed ID: 30352121
[TBL] [Abstract][Full Text] [Related]
6. Individualized treat-and-extend regime for optimization of real-world vision outcome and improved patients' persistence.
Volkmann I; Knoll K; Wiezorrek M; Greb O; Framme C
BMC Ophthalmol; 2020 Mar; 20(1):122. PubMed ID: 32228517
[TBL] [Abstract][Full Text] [Related]
7. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.
Solomon SD; Lindsley K; Vedula SS; Krzystolik MG; Hawkins BS
Cochrane Database Syst Rev; 2014 Aug; 8(8):CD005139. PubMed ID: 25170575
[TBL] [Abstract][Full Text] [Related]
8. Management and Outcomes for Neovascular Age-Related Macular Degeneration: Analysis of United States Electronic Health Records.
Kiss S; Campbell J; Almony A; Shih V; Serbin M; LaPrise A; Wykoff CC
Ophthalmology; 2020 Sep; 127(9):1179-1188. PubMed ID: 32345477
[TBL] [Abstract][Full Text] [Related]
9. Consistent Long-Term Therapy of Neovascular Age-Related Macular Degeneration Managed by 50 or More Anti-VEGF Injections Using a Treat-Extend-Stop Protocol.
Adrean SD; Chaili S; Ramkumar H; Pirouz A; Grant S
Ophthalmology; 2018 Jul; 125(7):1047-1053. PubMed ID: 29439828
[TBL] [Abstract][Full Text] [Related]
10. A systematic approach to evaluate practice-based process- and outcome data applied to the treatment of neovascular age-related macular degeneration.
van der Reis MI; Elshout M; Berendschot TTJM; de Jong-Hesse Y; Webers CAB; Schouten JSAG
BMC Ophthalmol; 2020 Jan; 20(1):21. PubMed ID: 31918701
[TBL] [Abstract][Full Text] [Related]
11. Visual Acuity Outcomes after Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 19.
Keenan TD; Vitale S; Agrón E; Domalpally A; Antoszyk AN; Elman MJ; Clemons TE; Chew EY;
Ophthalmol Retina; 2020 Jan; 4(1):3-12. PubMed ID: 31395505
[TBL] [Abstract][Full Text] [Related]
12. Association of Genetic Variants With Response to Anti-Vascular Endothelial Growth Factor Therapy in Age-Related Macular Degeneration.
Lorés-Motta L; Riaz M; Grunin M; Corominas J; van Asten F; Pauper M; Leenders M; Richardson AJ; Muether P; Cree AJ; Griffiths HL; Pham C; Belanger MC; Meester-Smoor MA; Ali M; Heid IM; Fritsche LG; Chakravarthy U; Gale R; McKibbin M; Inglehearn CF; Schlingemann RO; Omar A; Chen J; Koenekoop RK; Fauser S; Guymer RH; Hoyng CB; de Jong EK; Lotery AJ; Mitchell P; den Hollander AI; Baird PN; Chowers I
JAMA Ophthalmol; 2018 Aug; 136(8):875-884. PubMed ID: 29852030
[TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
14. Macular Atrophy Incidence and Progression in Eyes with Neovascular Age-Related Macular Degeneration Treated with Vascular Endothelial Growth Factor Inhibitors Using a Treat-and-Extend or a Pro Re Nata Regimen: Four-Year Results of the MANEX Study.
Spooner KL; Fraser-Bell S; Cozzi M; Staurenghi G; Invernizzi A; Monteduro D; Munk MR; Hong T; Chang AA
Ophthalmology; 2020 Dec; 127(12):1663-1673. PubMed ID: 32544561
[TBL] [Abstract][Full Text] [Related]
15. Real-world 10-year experiences with intravitreal treatment with ranibizumab and aflibercept for neovascular age-related macular degeneration.
Brynskov T; Munch IC; Larsen TM; Erngaard L; Sørensen TL
Acta Ophthalmol; 2020 Mar; 98(2):132-138. PubMed ID: 31282617
[TBL] [Abstract][Full Text] [Related]
16. Predicting visual outcomes in patients treated with aflibercept for neovascular age-related macular degeneration: Data from a real-world clinical setting.
Fulcher C; Hazel CA; Pacey I; Ali H; Ghanchi FD
Eur J Ophthalmol; 2020 May; 30(3):543-549. PubMed ID: 30935224
[TBL] [Abstract][Full Text] [Related]
17. TEN-YEAR FOLLOW-UP OF PATIENTS WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS.
Starr MR; Kung FF; Mejia CA; Bui YT; Bakri SJ
Retina; 2020 Sep; 40(9):1665-1672. PubMed ID: 31725524
[TBL] [Abstract][Full Text] [Related]
18. CORRELATION BETWEEN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AND VISUAL OUTCOMES AFTER ANTI-VEGF TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY.
Lee H; Ji B; Chung H; Kim HC
Retina; 2016 Mar; 36(3):465-75. PubMed ID: 26076214
[TBL] [Abstract][Full Text] [Related]
19. Lifetime Outcomes of Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration.
Finger RP; Puth MT; Schmid M; Barthelmes D; Guymer RH; Gillies M
JAMA Ophthalmol; 2020 Dec; 138(12):1234-1240. PubMed ID: 33057589
[TBL] [Abstract][Full Text] [Related]
20. Outcomes and Predictive Factors After Cataract Surgery in Patients With Neovascular Age-related Macular Degeneration. The Fight Retinal Blindness! Project.
Daien V; Nguyen V; Morlet N; Arnold JJ; Essex RW; Young S; Hunyor A; Gillies MC; Barthelmes D;
Am J Ophthalmol; 2018 Jun; 190():50-57. PubMed ID: 29550186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
